Depression screening
Pro Research Analysisby 
Searched over 200M research papers for "depression screening"
Depression Screening: An Overview of Current Research
Introduction to Depression Screening
Depression is a significant global health issue, often leading to disability and reduced quality of life. Effective screening for depression is crucial for early detection and management, particularly in primary care and hospital settings. This article synthesizes recent research on depression screening tools, their effectiveness, and the implications for clinical practice.
Patient Health Questionnaire-9 (PHQ-9) in Primary Care
Reliability and Validity of PHQ-9
The PHQ-9 is widely recognized as a reliable tool for depression screening in primary care settings. A systematic review of 42 studies highlighted its extensive validation, with sensitivity ranging from 0.37 to 0.98 and specificity from 0.42 to 0.99, depending on the cut-off scores used . The PHQ-9's summed-item scoring method at a cut-off point of 10 has shown better diagnostic performance compared to the algorithm scoring method, which tends to have lower sensitivity .
Psychometric Properties
A comprehensive review of depression screening tools in primary healthcare settings found that the PHQ-9 was the most extensively tested tool, with sensitivity and specificity values ranging from 28% to 100% and 43% to 100%, respectively . This variability underscores the importance of context and population in interpreting screening results.
Depression Screening in Hospitalized Patients
Feasibility and Outcomes
Screening for depression in hospitalized patients is feasible and can be effectively conducted using various tools, including self-administered questionnaires. The prevalence of depression in these settings ranges from 5% to 60%, with a median of 33% . Studies indicate that depression detected during hospitalization is associated with poorer functional outcomes, worse physical health, and higher readmission rates .
Screening Tools and Their Effectiveness
Center for Epidemiologic Studies Depression Scale (CES-D)
The CES-D is another commonly used tool for depression screening. A meta-analysis of 28 studies found that the CES-D has acceptable screening accuracy in general and primary care populations, with an area under the curve of 0.87. A cut-off score of 20 provides a better balance between sensitivity (0.83) and specificity (0.78) compared to the traditionally recommended cut-off of 16 .
Screening in Children and Adolescents
Depression screening in younger populations presents unique challenges. A systematic review of commonly used scales, such as the Children's Depression Inventory (CDI) and the Beck Depression Inventory (BDI), found that these tools are reliable but may result in many false positives when using cut-off scores to indicate clinical levels of depression . Sensitivity and specificity were moderate, highlighting the need for careful interpretation and follow-up diagnostic interviews.
Recommendations and Guidelines
U.S. Preventive Services Task Force (USPSTF) Recommendations
The USPSTF recommends screening adults for depression in clinical practices with systems in place to ensure accurate diagnosis, effective treatment, and follow-up. This recommendation is based on evidence that screening improves the identification of depressed patients and that treatment reduces clinical morbidity . However, a systematic review found no randomized controlled trials (RCTs) directly supporting the USPSTF guideline, suggesting the need for further research to validate these recommendations .
Clinical and Cost Effectiveness
Despite the widespread use of screening tools, there is substantial evidence that routine administration of these questionnaires has minimal impact on the detection, management, or outcome of depression by clinicians. A two-stage screening process may be more effective, but this approach requires further evaluation in large-scale trials .
Conclusion
Depression screening is a critical component of mental health care, particularly in primary care and hospital settings. Tools like the PHQ-9 and CES-D are widely used and validated, though their effectiveness can vary based on the population and setting. While current guidelines support depression screening, more research is needed to optimize screening strategies and ensure they lead to improved patient outcomes.
Sources and full results
Most relevant research papers on this topic